Ann: Positive FDA Pre-IND meeting guides IHL-675A development, page-40

To start this post let me clarify that I am 100% a believer in IHL and will continue to be a LT holder.

However,

as positive as this news is a large component has essentially been scrapped. EUA for the drug to treat covid sufferers was a large part of our project moving forward.. not only this but essentially it is sad to think now that so many people who are still suffering from covid whom may have had some hope from 675 are now going to miss out

furthermore, I believe some investors may have been looking forward to the near term revenues that EUA would of provided.

I am still 100% all in and very bullish on the future of IHL and am excited to see the positive results from human trials to come.

please correct me if I've interpreted anything wrong here!

GLTAH